Products of the isoprostane pathway: unique bioactive compounds and markers of lipid peroxidation

被引:143
作者
Roberts, LJ [1 ]
Morrow, JD
机构
[1] Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA
[2] Vanderbilt Univ, Dept Med, Nashville, TN 37232 USA
关键词
isoprostanes; lipid peroxidation; free radicals; protein adducts; isolevuglandins; mass spectrometry;
D O I
10.1007/s00018-002-8469-8
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We previously reported the discovery of prostaglandin F-2-like compounds (F-2-isoprostanes) formed by nonenzymatic free-radical-induced peroxidation of arachidonic acid. Quantification of F-2-isoprostanes has proven to be a major advance in assessing oxidative stress status in vivo. Central in the pathway of formation of isoprostanes are prostaglandin H-2-like endoperoxides, which also undergo rearrangement in vivo to form E-ring, D-ring, and thromboxane-ring compounds. E-2- and D-2-isoprostanes also undergo dehydration in vivo to form reactive cyclopentenone A(2)- and J(2)-isoprostanes, which are susceptible to Michael addition reactions with thiols. Recently, we described the formation of highly reactive gamma-ketoaldehydes (now termed isoketals) as products of isoprostane endoperoxide rearrangement which readily adduct to lysine residues on proteins and induce cross-links at rates that far exceed other aldehyde products of lipid peroxidation. Isoprostane-like compounds (neuroprostanes) and isoketal-like compounds (neuroketals) are formed from oxidation of docosahexaenoic acid, which is enriched in the brain, and measurement of neuroprostanes may provide a unique marker of oxidative neuronal injury.
引用
收藏
页码:808 / 820
页数:13
相关论文
共 118 条
[1]  
Aleynik SI, 1998, ALCOHOL CLIN EXP RES, V22, P192, DOI 10.1111/j.1530-0277.1998.tb03637.x
[2]  
ATSMON J, 1990, CANCER RES, V50, P1879
[3]   FORMATION OF THIOL CONJUGATES OF 9-DEOXY-DELTA-9,DELTA-12(E)-PROSTAGLANDIN-D2 AND DELTA-12(E)-PROSTAGLANDIN-D2 [J].
ATSMON, J ;
SWEETMAN, BJ ;
BAERTSCHI, SW ;
HARRIS, TM ;
ROBERTS, LJ .
BIOCHEMISTRY, 1990, 29 (15) :3760-3765
[4]   PGA - FACT, NOT ARTIFACT [J].
ATTALLAH, A ;
PAYAKKAPAN, W ;
LEE, J ;
CARR, A ;
BRAZELTON, E .
PROSTAGLANDINS & OTHER LIPID MEDIATORS, 1974, 5 (01) :69-72
[5]   Demonstration of halothane-induced hepatic lipid peroxidation in rats by quantification of F-2-isoprostanes [J].
Awad, JA ;
Horn, JL ;
Roberts, LJ ;
Franks, JJ .
ANESTHESIOLOGY, 1996, 84 (04) :910-916
[6]  
AWAD JA, 1994, J PHARMACOL EXP THER, V270, P858
[7]   DETECTION AND LOCALIZATION OF LIPID-PEROXIDATION IN SELENIUM-DEFICIENT AND VITAMIN-E-DEFICIENT RATS USING F-2-ISOPROSTANES [J].
AWAD, JA ;
MORROW, JD ;
HILL, KE ;
ROBERTS, LJ ;
BURK, RF .
JOURNAL OF NUTRITION, 1994, 124 (06) :810-816
[8]   EFFECTS OF A NOVEL PROSTAGLANDIN, 8-EPI-PGF2-ALPHA, IN RABBIT LUNG INSITU [J].
BANERJEE, M ;
KANG, KH ;
MORROW, JD ;
ROBERTS, LJ ;
NEWMAN, JH .
AMERICAN JOURNAL OF PHYSIOLOGY, 1992, 263 (03) :H660-H663
[9]   Formation of highly reactive γ-ketoaldehudes (Neuroketals) as products of the neuroprostane pathway [J].
Bernoud-Hubac, N ;
Davies, SS ;
Boutaud, O ;
Montine, TJ ;
Roberts, LJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (33) :30964-30970
[10]   Characterization of the lysyl adducts formed from prostaglandin H2 via the levuglandin pathway [J].
Boutaud, O ;
Brame, CJ ;
Salomon, RG ;
Roberts, LJ ;
Oates, JA .
BIOCHEMISTRY, 1999, 38 (29) :9389-9396